Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate hears AB 260 to protect access to medication abortion and telehealth services in California
Summary
AB 260 would protect access to mifepristone and expand telehealth delivery and labeling protections for medication abortion in California. Supporters said federal threats to approvals make state protections urgent; testimony included clinicians and reproductive‑rights groups. The measure advanced from committee.
Majority Leader (presenting AB 260) and bill supporters told the Senate Health Committee that the measure is designed to protect access to medication abortion — specifically mifepristone — and telehealth delivery in the face of recent federal threats and regulatory uncertainty.
The majority leader described AB 260 as “an important proposal to protect safe and legal reproductive health care here in California,” saying the bill would shield clinicians, pharmacists and clinics from disciplinary or licensure penalties for lawfully providing mifepristone and would…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
